International Journal of Molecular Sciences | |
Cardiac Pathology in Myotonic Dystrophy Type 1 | |
Mani S. Mahadevan1  Ramesh S. Yadava1  Mahua Mandal1  | |
[1] Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA; | |
关键词: myotonic dystrophy; RNA toxicity; cardiac pathology; cardiac conduction; triplet repeat mutation; antisense oligonucleotides; | |
DOI : 10.3390/ijms222111874 | |
来源: DOAJ |
【 摘 要 】
Myotonic dystrophy type 1 (DM1), the most common muscular dystrophy affecting adults and children, is a multi-systemic disorder affecting skeletal, cardiac, and smooth muscles as well as neurologic, endocrine and other systems. This review is on the cardiac pathology associated with DM1. The heart is one of the primary organs affected in DM1. Cardiac conduction defects are seen in up to 75% of adult DM1 cases and sudden death due to cardiac arrhythmias is one of the most common causes of death in DM1. Unfortunately, the pathogenesis of cardiac manifestations in DM1 is ill defined. In this review, we provide an overview of the history of cardiac studies in DM1, clinical manifestations, and pathology of the heart in DM1. This is followed by a discussion of emerging data about the utility of cardiac magnetic resonance imaging (CMR) as a biomarker for cardiac disease in DM1, and ends with a discussion on models of cardiac RNA toxicity in DM1 and recent clinical guidelines for cardiologic management of individuals with DM1.
【 授权许可】
Unknown